Literature DB >> 23169432

Response to "Drug interactions produced by proton pump inhibitors: not simply a pH effect".

N R Budha, L Z Benet, J A Ware.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23169432     DOI： 10.1038/clpt.2012.206

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

1.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

2.  Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations.

Authors:  Jerry Li; Dana Nickens; Keith Wilner; Weiwei Tan
Journal:  Oncol Ther       Date:  2021-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.